The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...

Doxycycline postexposure prophylaxis (doxyPEP) involves taking an antibiotic soon after sex without a barrier method to ...

Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. today appointed two obstetricians-gynecologists to the ...

The Coalition for Epidemic Preparedness Innovations (CEPI) announced earlier today that the University of Oxford has entered ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

The Pitt season 2 is already off to an intense start with numerous patients arriving at the Pittsburgh Trauma Medical ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026. Edgewise Chief ...

Skip the pharmacy line. These 19 trusted online pharmacies make refilling and managing your prescriptions easier, faster, and more convenient.

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin is the ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.